Getty Images soars on report that Shutterstock is interested in a merger
[ad_1]
Getty Images soars on report that Shutterstock is interested in a merger
[ad_2]
[ad_1] Grandbrothers Johnson & Johnson (NYSE:JNJ) has received Priority Review designation from the FDA for the Biologics License Application for its drug nipocalimab in the treatment of antibody-positive patients with generalized myasthenia gravis. Nipocalimab was also recently granted Breakthrough Therapy Designation by [ad_2]
[ad_1] Oki Electric and FPT enter strategic partnership [ad_2]
[ad_1] Flanigan's GAAP EPS of $1.81, revenue of $188.32M [ad_2]
[ad_1] Nvidia, AMD vie for AI supremacy with latest offerings at CES [ad_2]
[ad_1] Hologic says Q1 EPS expected to be near high end of guidance ranges [ad_2]
[ad_1] Arbutus Biopharma (NASDAQ:ABUS) announced on Monday its 2025 corporate objectives and provided a financial update. The company had cash, cash equivalents and investments in marketable securities totaling approximately $123 million as of December 31, 2024. The company expects to significantly [ad_2]